Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Bolli

Circulation research

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Circulation Research|August 31, 2013
Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directionsSantosh K Sanganalmath, Roberto Bolli
Circulation Research|March 28, 2015
"String theory" of c-kit(pos) cardiac cells: a new paradigm regarding the nature of these cells that may reconcile apparently discrepant resultsMatthew C L Keith, Roberto Bolli
Circulation Research|July 7, 2018
New Paradigms in Cell Therapy: Repeated Dosing, Intravenous Delivery, Immunomodulatory Actions, and New Cell TypesMarcin Wysoczynski, Abdur Khan, Roberto Bolli
Circulation Research|July 7, 2018
Clinical Studies of Cell Therapy in Cardiovascular Medicine: Recent Developments and Future DirectionsMonisha N Banerjee, Roberto Bolli, Joshua M Hare
Circulation Research|July 24, 2004
Myocardial protection at a crossroads: the need for translation into clinical therapyRoberto Bolli, Lance Becker, Garrett Gross, et al.
Circulation Research|March 23, 2002
Inducible nitric oxide synthase modulates cyclooxygenase-2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioningKen Shinmura, Yu-Ting Xuan, Xian-Liang Tang, et al.
Circulation Research|May 29, 2004
Cardioprotection during the final stage of the late phase of ischemic preconditioning is mediated by neuronal NO synthase in concert with cyclooxygenase-2Yang Wang, Eitaro Kodani, Jianxun Wang, et al.
Circulation Research|February 4, 2016
Impact of Cell Therapy on Myocardial Perfusion and Cardiovascular Outcomes in Patients With Angina Refractory to Medical Therapy: A Systematic Review and Meta-AnalysisAbdur Rahman Khan, Talha A Farid, Asif Pathan, et al.
Circulation Research|August 10, 2002
Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioningKen Shinmura, Roberto Bolli, Si-Qi Liu, et al.
Circulation Research|February 4, 2016
Long-Term Outcome of Administration of c-kit(POS) Cardiac Progenitor Cells After Acute Myocardial Infarction: Transplanted Cells Do not Become Cardiomyocytes, but Structural and Functional Improvement and Proliferation of Endogenous Cells Persist for at Least One YearXian-Liang Tang, Qianhong Li, Gregg Rokosh, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Circulation Research|August 31, 2013
Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directionsSantosh K Sanganalmath, Roberto Bolli
Circulation Research|March 28, 2015
"String theory" of c-kit(pos) cardiac cells: a new paradigm regarding the nature of these cells that may reconcile apparently discrepant resultsMatthew C L Keith, Roberto Bolli
Circulation Research|July 7, 2018
New Paradigms in Cell Therapy: Repeated Dosing, Intravenous Delivery, Immunomodulatory Actions, and New Cell TypesMarcin Wysoczynski, Abdur Khan, Roberto Bolli
Circulation Research|July 7, 2018
Clinical Studies of Cell Therapy in Cardiovascular Medicine: Recent Developments and Future DirectionsMonisha N Banerjee, Roberto Bolli, Joshua M Hare
Circulation Research|July 24, 2004
Myocardial protection at a crossroads: the need for translation into clinical therapyRoberto Bolli, Lance Becker, Garrett Gross, et al.
Circulation Research|March 23, 2002
Inducible nitric oxide synthase modulates cyclooxygenase-2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioningKen Shinmura, Yu-Ting Xuan, Xian-Liang Tang, et al.
Circulation Research|May 29, 2004
Cardioprotection during the final stage of the late phase of ischemic preconditioning is mediated by neuronal NO synthase in concert with cyclooxygenase-2Yang Wang, Eitaro Kodani, Jianxun Wang, et al.
Circulation Research|February 4, 2016
Impact of Cell Therapy on Myocardial Perfusion and Cardiovascular Outcomes in Patients With Angina Refractory to Medical Therapy: A Systematic Review and Meta-AnalysisAbdur Rahman Khan, Talha A Farid, Asif Pathan, et al.
Circulation Research|August 10, 2002
Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioningKen Shinmura, Roberto Bolli, Si-Qi Liu, et al.
Circulation Research|February 4, 2016
Long-Term Outcome of Administration of c-kit(POS) Cardiac Progenitor Cells After Acute Myocardial Infarction: Transplanted Cells Do not Become Cardiomyocytes, but Structural and Functional Improvement and Proliferation of Endogenous Cells Persist for at Least One YearXian-Liang Tang, Qianhong Li, Gregg Rokosh, et al.
Pageof 3